Vita W. Jongen

665 total citations
39 papers, 310 citations indexed

About

Vita W. Jongen is a scholar working on Epidemiology, Infectious Diseases and Sociology and Political Science. According to data from OpenAlex, Vita W. Jongen has authored 39 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Infectious Diseases and 12 papers in Sociology and Political Science. Recurrent topics in Vita W. Jongen's work include HIV/AIDS Research and Interventions (18 papers), Sex work and related issues (11 papers) and HIV, Drug Use, Sexual Risk (11 papers). Vita W. Jongen is often cited by papers focused on HIV/AIDS Research and Interventions (18 papers), Sex work and related issues (11 papers) and HIV, Drug Use, Sexual Risk (11 papers). Vita W. Jongen collaborates with scholars based in Netherlands, Canada and South Africa. Vita W. Jongen's co-authors include Maarten F. Schim van der Loeff, Henry J.C. de Vries, Maria Prins, Elske Hoornenborg, Anders Boyd, Udi Davidovich, Hanne M. L. Zimmermann, Liza Coyer, Jan M. Prins and Kerstin Klipstein‐Grobusch and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Vita W. Jongen

36 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vita W. Jongen Netherlands	12	159	136	69	56	54	39	310
Michaela Maynard United States	10	125 0.8×	124 0.9×	48 0.7×	53 0.9×	37 0.7×	26	292
C. van der Horst United States	9	168 1.1×	121 0.9×	96 1.4×	26 0.5×	119 2.2×	11	357
Nashaba Matin United Kingdom	8	129 0.8×	153 1.1×	47 0.7×	27 0.5×	106 2.0×	14	295
Jennifer Chang United States	10	144 0.9×	114 0.8×	52 0.8×	49 0.9×	21 0.4×	19	303
Monika Kamkuemah South Africa	9	102 0.6×	125 0.9×	37 0.5×	43 0.8×	48 0.9×	12	266
Ali Elgalib Oman	11	128 0.8×	170 1.3×	29 0.4×	22 0.4×	28 0.5×	31	281
Nicholas P. DeGroote United States	11	129 0.8×	125 0.9×	50 0.7×	38 0.7×	23 0.4×	35	340
Catriona Ooi Australia	11	243 1.5×	189 1.4×	73 1.1×	64 1.1×	53 1.0×	45	395
Erica Hardy United States	5	100 0.6×	64 0.5×	180 2.6×	62 1.1×	116 2.1×	18	308
Sawsan AlMukdad Qatar	9	109 0.7×	46 0.3×	30 0.4×	21 0.4×	20 0.4×	18	199

Countries citing papers authored by Vita W. Jongen

Since Specialization

Citations

This map shows the geographic impact of Vita W. Jongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vita W. Jongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vita W. Jongen more than expected).

Fields of papers citing papers by Vita W. Jongen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vita W. Jongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vita W. Jongen. The network helps show where Vita W. Jongen may publish in the future.

Co-authorship network of co-authors of Vita W. Jongen

This figure shows the co-authorship network connecting the top 25 collaborators of Vita W. Jongen. A scholar is included among the top collaborators of Vita W. Jongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vita W. Jongen. Vita W. Jongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoornenborg, Elske, Maarten F. Schim van der Loeff, Anders Boyd, et al.. (2025). Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024. Eurosurveillance. 30(26). 1 indexed citations

Wit, Ferdinand W.N.M., Vita W. Jongen, Kees Brinkman, et al.. (2025). Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk. Clinical Infectious Diseases.

Jongen, Vita W., Ferdinand W N M Wit, Anders Boyd, et al.. (2025). Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort. The Lancet HIV. 12(1). e40–e50. 5 indexed citations

Jongen, Vita W., et al.. (2024). Human papillomavirus infection among adolescents living with HIV: a focus on prevention. Current Opinion in HIV and AIDS. 19(6). 361–367. 2 indexed citations

Boyd, Anders, Vita W. Jongen, Liza Coyer, et al.. (2024). Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort. PLoS Medicine. 21(5). e1004328–e1004328. 5 indexed citations

Jongen, Vita W., Daniela Bezemer, Ard van Sighem, et al.. (2024). Oral HIV pre-exposure prophylaxis use and resistance-associated mutations among men who have sex with men and transgender persons newly diagnosed with HIV in the Netherlands: results from the ATHENA cohort, 2018 to 2022. Eurosurveillance. 29(38). 1 indexed citations

Zalm, Marieke M. van der, Vita W. Jongen, Brian Allwood, et al.. (2024). Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completion. EClinicalMedicine. 67. 102406–102406. 14 indexed citations

Loeff, Maarten F. Schim van der, et al.. (2024). Increase inNeisseria gonorrhoeaeinfections after ending COVID-19 lockdown measures in Amsterdam, the Netherlands. Sexually Transmitted Infections. 101(3). 152–159.

Jongen, Vita W., et al.. (2024). Seroconversion in syphilis screening without positive confirmatory tests points at early infection. Sexually Transmitted Infections. 100(3). 138–142. 1 indexed citations

10.

Heukelom, Matthijs L. Siegenbeek van, Vita W. Jongen, J. Schouten, et al.. (2023). Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022. Journal of the European Academy of Dermatology and Venereology. 37(9). 1891–1896. 9 indexed citations

11.

Boyd, Anders, Liza Coyer, Hannelore M Götz, et al.. (2023). Online-Mediated HIV Pre-exposure Prophylaxis Care and Reduced Monitoring Frequency for Men Who Have Sex With Men: Protocol for a Randomized Controlled Noninferiority Trial (EZI-PrEP Study). JMIR Research Protocols. 12. e51023–e51023. 2 indexed citations

12.

Jongen, Vita W., et al.. (2023). Sexual Distancing During 5 Periods Around and During the COVID-19 Pandemic, Amsterdam, the Netherlands. Sexually Transmitted Diseases. 51(1). 72–80. 1 indexed citations

13.

Jongen, Vita W., Anders Boyd, Nicole H. T. M. Dukers–Muijrers, et al.. (2023). What determines mpox vaccination uptake? Assessing the effect of intent-to-vaccinate versus other determinants among men who have sex with men. Vaccine. 42(2). 186–193. 11 indexed citations

14.

Jongen, Vita W., Thijs Reyniers, Maarten F. Schim van der Loeff, et al.. (2023). Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies. Journal of the International AIDS Society. 26(7). e26133–e26133. 3 indexed citations

15.

Jongen, Vita W., Hanne M. L. Zimmermann, Johannes A. Bogaards, et al.. (2022). Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study. Sexually Transmitted Infections. 99(3). sextrans–2022. 9 indexed citations

16.

Vries, Henry J.C. de, Vita W. Jongen, Titia Heijman, et al.. (2022). Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial. The Lancet Infectious Diseases. 22(5). 706–717. 29 indexed citations

17.

Jongen, Vita W., et al.. (2022). Approaches to Estimating Clearance Rates for Human Papillomavirus Groupings: A Systematic Review and Real Data Examples. Epidemiology. 34(1). 119–130. 4 indexed citations

18.

Jongen, Vita W., Hanne M. L. Zimmermann, Anders Boyd, et al.. (2021). Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes. 87(5). 1111–1118. 24 indexed citations

19.

Jongen, Vita W., Martijn S. van Rooijen, Maarten F. Schim van der Loeff, et al.. (2020). Evaluation of the Hepatitis C Testing Strategy for Human Immunodeficiency Virus–Positive Men Who Have Sex With Men at the Sexually Transmitted Infections Outpatient Clinic of Amsterdam, the Netherlands. Sexually Transmitted Diseases. 47(9). 587–595. 3 indexed citations

20.

Jongen, Vita W., Olivier Richel, Elske Marra, et al.. (2019). Anal Squamous Intraepithelial Lesions (SILs) in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men: Incidence and Risk Factors of SIL and of Progression and Clearance of Low-Grade SILs. The Journal of Infectious Diseases. 222(1). 62–73. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact